Capturing Robust PRO Data in a Breast Cancer Trial

A pharmaceutical company conducting a multi-site, observational study sought to better understand how their treatment and treatment-related adverse events (AEs) impact daily life for advanced breast cancer patients.

They partnered with Signant to provide patients with electronic patient-reported outcomes diaries coupled with integrated wearable devices that automatically capture physical activity and sleep data. These data helped the sponsor measure correlations between treatment effects and quality of life.

Read our case study to learn how Signant’s eCOA solutions helped collect accurate and robust data from patients for a more comprehensive evaluation of treatment efficacy and safety.